BIOTECHNOLOGICAL PRODUCTS

Brand Owner (click to sort) Address Description
ACTIFAC HTS BIO, SA 180, AVENUE DE LA ROQUE FORCADE GEMENOS 13420 France biotechnological products, namely, chemicals for use in treating, improving, and deodorizing animal excrement for animal husbandry;
AZOFAC HTS BIO, SA 180, AVENUE DE LA ROQUE FORCADE GEMENOS 13420 France biotechnological products, namely, chemicals for use in treating, improving, and deodorizing animal excrement for animal husbandry;
AZOFAC SENAN, Alain 99, avenue du General Leclerc 94700 Maisons-Alfort France biotechnological products, namely, chemicals for use in treating, improving, and deodorizing animal excrement for animal husbandry;
NUCLEOPUR Benev Company Incorporated 26772 Vista Terrace Lake Forest CA 92630 Biotechnological products, namely, instruments for laboratory research, namely, cartridges and columns for the isolation and purification of nucleic acids;NUCLEIC PURE;
ORIGAMI Origami Biosciences Inc. 1500 Main Street, Suite 2700 Springfield MA 01115 Biotechnological products, namely, bio-chips for scientific purposes;Biotechnological products, namely, diagnostic reagents, medicines for gene therapy for the treatment of genetic diseases and/or cancer for medical purposes; Medicines for treating genetic disorders; Nanoparticles carrying drugs and nucleic acids for treating cancers; Synthetic peptide based nanoparticles for gene therapy for the treatment of genetic diseases and/or cancer; protein-based nanoparticles for gene therapy for the treatment of genetic diseases and/or cancer; cell-based therapeutic products, namely, vaccines; Pharmaceutical compounds for gene therapy for the treatment of genetic diseases and/or cancer; Biological material, namely, biological diagnostic preparations for gene therapy for the treatment of genetic diseases and/or cancer; Nucleic acids for medical purposes; proteins arrays for medical diagnosis purposes; cells for medical use; self-replicating nucleic acids for medical purposes; peptides for gene therapy for the treatment of genetic diseases and/or cancer; Eukaryotic cells for medical purposes; Prokaryotic cells for medical purposes; Stem cells for medical purposes; Living cells for medical purposes; Pharmaceutical compounds for gene therapy for the treatment of genetic diseases and/or cancer, vaccines, diagnostic rubbing compounds for medical purposes; Delivery vehicles, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Reagents for medical purposes; Diagnostic reagents for medicinal use; Bacteria for medical purposes; Diagnostic bacteria for medicinal use; Biochemical compounds for gene therapy for the treatment of genetic diseases and/or cancer for medical and veterinary application; Vaccines for medical and veterinary use;Biotechnological products, namely, chemicals for use in biotechnological product development for scientific purposes; Biological material, namely, biochemical preparations for scientific purposes; Cells for scientific purposes; Eukaryotic cells for scientific purposes; Prokaryotic cells for scientific purposes; Stem cells for scientific purposes; Living cells for scientific purposes; Reagents for scientific purposes; Diagnostic reagents for scientific use; Bacteria for scientific purposes; Diagnostic biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for scientific purposes; Nucleic acid for laboratory use; Proteins for use in manufacture; Small molecules being chemical compounds for use in patterning at nano scale or near nano scale;Consultancy in the field of biotechnology; Research and development in the field of biotechnology; Research and development in the field of immunology; Research and development in the field of biochemistry;
VIVOGEN MacLaren, Duncan, Charles 535 Gayley Ave. #211 Los Angeles CA 90024 BIOTECHNOLOGICAL PRODUCTS, NAMELY, ORGANISMS, TISSUES, CELLS, PROTEINS, NUCLEIC ACIDS, SMALL MOLECULES, OR CHEMICALS FOR RESEARCH, PRODUCTION, OR TREATMENT IN THE FIELDS OF REGENERATION, REPRODUCTION, CLONING, HEALING, MODIFICATION, GENE THERAPY, OR GERONTOLOGY;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The present invention provides a novel process of neutralizing textile industrial wastewater by a bacterial strain isolated in India. The isolated bacterial strain is capable to bring down the pH of wastewater from 12.00 to 7.00 units within two hours. The neutralization of alkaline textile industrial wastewater by such biotechnological process is highly effective and economical as compared to conventional neutralization by chemical means. This biotechnological process may find wide commercial application in textile industries emanating alkaline wastewater.